Publications searcher

The science produced by our scientists is very important. In 2024, 1,501 papers were published in scientific journals with an average impact factor of over 7.13 points.

Pharmacokinetics of cefiderocol during extracorporeal membrane oxygenation: A case report.

PMID: 36853601
Journal: PERFUSION-UK
Year: 2023
Reference: Perfusion. 2023 May;38(1_suppl):40-43. doi: 10.1177/02676591231160462. Epub 2023 Feb 28.
Impact factor:
Publication type: Paper in international publication
Authors: Domenech, Josep; Domenech, Laura; Ferrer, Ricard; Gallart, Elisabet; Garcia, Sonia; Garcia, Sonia; Giron, Pilar; Lamora, Anna; Lamora, Anna; Nuvials, Xavier et al.
DOI: 10.1177/02676591231160462

Pharmacokinetics (PK) of Tiragolumab in First-in-Human Study in Patients With Mixed Solid Tumors (GO30103).

PMID: 38105505
Journal: JOURNAL OF CLINICAL PHARMACOLOGY
Year: 2023
Reference: J Clin Pharmacol. 2023 Dec 17. doi: 10.1002/jcph.2397.
Impact factor:
Publication type: Paper in international publication
Authors: Bedard, Philippe L; Calvo, Emiliano; Cervantes, Andres; Cho, Byoung Chul; Delord, Jean-Pierre; Ding, Hao; Garralda, Elena; Hendricks, Robert; Italiano, Antoine; Kim, Tae Won et al.
DOI: 10.1002/jcph.2397

Phase 1 first-in-human dose-escalation study of ANV419 in patients with relapsed/refractory advanced solid tumors.

PMID: 38243906
Journal: Journal for ImmunoTherapy of Cancer
Year: 2023
Reference: J Immunother Cancer. 2023 Nov 21;11(11):e007784. doi: 10.1136/jitc-2023-007784.
Impact factor:
Publication type: Paper in international publication
Authors: Alonso, Guzman; Alonso-Saladrigues, Anna; Bucher, Christoph; Caballero-Velazquez, Teresa; Calvo, Emiliano; Castillo-Robleda, Ana; Corral de la Fuente, Elena; Delgado-Serrano, Javier; Diaz-de-Heredia, Cristina; Faura, Anna et al.
DOI: 10.1136/jitc-2023-007784

Phase 1 study of JNJ-64619178, a protein arginine methyltransferase 5 inhibitor, in patients with lower-risk myelodysplastic syndromes.

PMID: 37776843
Journal: LEUKEMIA RESEARCH
Year: 2023
Reference: Leuk Res. 2023 Sep 20;134:107390. doi: 10.1016/j.leukres.2023.107390.
Impact factor:
Publication type: Paper in international publication
Authors: Alfonso-Pierola, Ana; Avivi, Irit; Brown, Regina J; Brunner, Andrew M; Cadenas, Felix Lopez; Chromik, Joerg; Falantes, Jose; Germing, Ulrich; Gu, Junchen; Haque, Tamanna et al.
DOI: 10.1016/j.leukres.2023.107390

Phase 2 trial of bintrafusp alfa as second-line therapy for patients with locally advanced/metastatic biliary tract cancers.

PMID: 36999533
Journal: HEPATOLOGY
Year: 2023
Reference: Hepatology. 2023 Sep 1;78(3):758-770. doi: 10.1097/HEP.0000000000000365. Epub 2023 Apr 1.
Impact factor:
Publication type: Paper in international publication
Authors: Azad, Nilofer; Bajars, Marcis; Borad, Mitesh J; Bridgewater, John; Cubillo, Antonio; de Braud, Filippo; Furuse, Junji; Hijioka, Susumu; Javle, Milind M; Kim, Jin Won et al.
DOI: 10.1097/HEP.0000000000000365

Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer.

PMID: 37870969
Journal: NEW ENGLAND JOURNAL OF MEDICINE
Year: 2023
Reference: N Engl J Med. 2023 Oct 21. doi: 10.1056/NEJMoa2309719.
Impact factor:
Publication type: Paper in international publication
Authors: Adam-Artigues, Anna; Arenas, Enrique J; Arribas, Joaquin; Bardet, Stephane; Brose, Marcia S; Capdevila, Jaume; Cejalvo, Juan Miguel; Elisei, Rossella; Fuhrer, Dagmar; Gao, Ming et al.
DOI: 10.1056/NEJMoa2309719

Phase Ia/b Study of Giredestrant +/-Palbociclib and +/-Luteinizing Hormone-releasing Hormone Agonists in Estrogen Receptor-positive, HER2-negative, Locally Advanced/Metastatic Breast Cancer.

PMID: 37921755
Journal: CLINICAL CANCER RESEARCH
Year: 2023
Reference: Clin Cancer Res. 2023 Nov 3. doi: 10.1158/1078-0432.CCR-23-1796.
Impact factor:
Publication type: Paper in international publication
Authors: Bardia, Aditya; Bellet-Ezquerra, Meritxell; Bond, John W; Boni, Valentina; Buti, Maria; Casado, Miguel Angel; Chang, Ching-Wei; Dominguez-Hernandez, Raquel; Eng-Wong, Jennifer; Esteban, Rafael et al.
DOI: 10.1158/1078-0432.CCR-23-1796

Phase II Study Investigating the Safety and Efficacy of Savolitinib and Durvalumab in Metastatic Papillary Renal Cancer (CALYPSO).

PMID: 36809050
Journal: JOURNAL OF CLINICAL ONCOLOGY
Year: 2023
Reference: J Clin Oncol. 2023 May 10;41(14):2493-2502. doi: 10.1200/JCO.22.01414. Epub 2023 Feb 21.
Impact factor:
Publication type: Paper in international publication
Authors: Glen, Hilary; Hartmaier, Ryan; Larkin, James M G; Markovets, Aleksandra; Mendez-Vidal, Maria Jose; Mousa, Kelly; Patel, Poulam; Powles, Thomas; Prendergast, Aaron; Ralph, Christy et al.
DOI: 10.1200/JCO.22.01414

Phase II trial of afatinib in patients with advanced urothelial carcinoma with genetic alterations in ERBB1-3 (LUX-Bladder 1).

PMID: 38102226
Journal: BRITISH JOURNAL OF CANCER
Year: 2023
Reference: Br J Cancer. 2023 Dec 15. doi: 10.1038/s41416-023-02513-6.
Impact factor:
Publication type: Paper in international publication
Authors: Aldecoa, Iban; Araujo, Silvia G; Buti, Maria; Castellano, Daniel; Climent, Miguel A; Fernandez, Emma; Fernandez, Pedro L; Font, Albert; Forns, Xavier; Gibson, Neil et al.
DOI: 10.1038/s41416-023-02513-6

Phase II Trial of Atezolizumab Combined With Carboplatin and Pemetrexed for Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer With Untreated Brain Metastases (Atezo-Brain, GECP17/05).

PMID: 37603816
Journal: JOURNAL OF CLINICAL ONCOLOGY
Year: 2023
Reference: J Clin Oncol. 2023 Aug 21:JCO2202561. doi: 10.1200/JCO.22.02561.
Impact factor:
Publication type: Paper in international publication
Authors: Blasco, Ana; Bruna, Jordi; De Castro, Javier; Estival, Anna; Felip, Enriqueta; Guirado, Maria; Huidobro, Gerardo; Juan, Oscar; Lopez, Rafael; Massuti, Bartomeu et al.
DOI: 10.1200/JCO.22.02561

Philadelphia-negative chronic myeloproliferative neoplasm follow-up: when the phone rings. Changes during the COVID-19 pandemic and patient satisfaction. Experience in 30 health centers in Spain.

PMID: 36422672
Journal: ANNALS OF HEMATOLOGY
Year: 2023
Reference: Ann Hematol. 2023 Feb;102(2):447-456. doi: 10.1007/s00277-022-05044-x. Epub 2022 Nov 23.
Impact factor:
Publication type: Paper in international publication
Authors: Alvarez-Larran, Alberto; Blum Dominguez, Alejandra; Caballero Navarro, Gonzalo; Caceres Sansaloni, Amparo; Carbonell, Sara; Cobo Rodriguez, Maria Teresa; Diaz, Alvaro; Duran, M Antonia; Fernandez Rodriguez, Angeles; Fox, Maria Laura et al.
DOI: 10.1007/s00277-022-05044-x

PHYOX2: A Pivotal Randomized Study of Nedosiran in Primary Hyperoxaluria Type 1 or 2.

PMID: 36007597
Journal: KIDNEY INTERNATIONAL
Year: 2023
Reference: Kidney Int. 2023 Jan;103(1):207-217. doi: 10.1016/j.kint.2022.07.025. Epub 2022 Aug 22.
Impact factor:
Publication type: Paper in international publication
Authors: Amrite, Aniruddha; Ariceta, Gema; Baum, Michelle A; Belostotsky, Vladimir; Cochat, Pierre; Forbes, Thomas A; Groothoff, Jaap; Hamamoto, Shuzo; Hayes, Wesley; Hoppe, Bernd et al.
DOI: 10.1016/j.kint.2022.07.025

Physical activity and exercise for the prevention and management of mild cognitive impairment and dementia: a collaborative international guideline.

PMID: 37768499
Journal: European Geriatric Medicine
Year: 2023
Reference: Eur Geriatr Med. 2023 Sep 28. doi: 10.1007/s41999-023-00858-y.
Impact factor:
Publication type: Paper in international publication
Authors: Alves, Mariana; Ars, Joan; Ars, Joan; Bahat, Gulistan; Barbagallo, Mario; Barbagallo, Mario; Bauer, Jurgen; Bautman, Ivan; Bazan, Laura Monica Perez; Brugiavini, Agar et al.
DOI: 10.1007/s41999-023-00858-y

Physical Activity in Multiple Sclerosis: Meeting the Guidelines at the Time of the COVID-19 Pandemic.

PMID: 36753458
Journal: Journal of Neurologic Physical Therapy
Year: 2023
Reference: J Neurol Phys Ther. 2023 Apr 1;47(2):112-121. doi: 10.1097/NPT.0000000000000430. Epub 2023 Jan 31.
Impact factor:
Publication type: Paper in international publication
Authors: Arntzen, Ellen Christin; Coote, Susan; Gungor, Feray; Jonsdottir, Johanna; Kalron, Alon; Kos, Daphne; Learmonth, Yvonne; Moumdjian, Lousin; Nedeljkovic, Una; Novotna, Klara et al.
DOI: 10.1097/NPT.0000000000000430

Pituitary macroadenomas in childhood and adolescence: a clinical analysis of 7 patients.

PMID: 37908013
Journal:
Year: 2023
Reference: Clin Diabetes Endocrinol. 2023 Oct 31;9(1):5. doi: 10.1186/s40842-023-00153-6.
Impact factor:
Publication type: Paper in international publication
Authors: Abbas, Amr E; Aguilar-Riera, Cristina; Al-Azizi, Karim M; Biagetti, Betina; Calabuig, Alvaro; Campos-Martorell, Ariadna; Clemente, Maria; Conradi, Lenard; Fabregas, Anna; Fernandez-Nofrerias, Eduard et al.
DOI: 10.1186/s40842-023-00153-6

Plain language summary of the CheckMate 816 study results: nivolumab plus chemotherapy given before surgery for non-small-cell lung cancer.

PMID: 36815433
Journal: Future Oncology
Year: 2023
Reference: Future Oncol. 2023 Feb 23. doi: 10.2217/fon-2023-0007.
Impact factor:
Publication type: Letter or abstract
Authors: Awad, Mark M; Balli, David; Brahmer, Julie R; Broderick, Stephen R; Cai, Junliang; Calvet, Christophe Y; Chen, Ke Neng; Ciuleanu, Tudor-Eliade; Dorange, Cecile; Felip, Enriqueta et al.
DOI: 10.2217/fon-2023-0007

Plasmatic BRAF-V600E allele fraction as a prognostic factor in metastatic colorectal cancer treated with BRAF combinatorial treatments.

PMID: 36921693
Journal: ANNALS OF ONCOLOGY
Year: 2023
Reference: Ann Oncol. 2023 Jun;34(6):543-552. doi: 10.1016/j.annonc.2023.02.016. Epub 2023 Mar 14.
Impact factor:
Publication type: Paper in international publication
Authors: Antista, M; Baraibar, I; Boccaccino, A; Comas, R; Cremolini, C; Dientsmann, R; Elez, E; Garcia, A; Martin, A; Martinelli, E et al.
DOI: 10.1016/j.annonc.2023.02.016

Platelet Analysis in the Thrombus Plus Serum BNP for Detecting Clot-Related Atrial Fibrillation. Results From the ITACAT Multicentric Registry.

PMID: 38091189
Journal: Translational Stroke Research
Year: 2023
Reference: Transl Stroke Res. 2023 Dec 13. doi: 10.1007/s12975-023-01220-x.
Impact factor:
Publication type: Paper in international publication
Authors: Camacho, Jessica; de-la-Torre, Carolina; Dorado, Laura; Garcia-Tornel, Alvaro; Hernandez, David; Hernandez-Perez, Maria; Juega, Jesus; Lazaro, Carlos; Molina, Carlos; Muchada, Marian et al.
DOI: 10.1007/s12975-023-01220-x

Platform trials as the way forward in infectious disease' clinical research: the case of COVID-19.

PMID: 36462745
Journal: CLINICAL MICROBIOLOGY AND INFECTION
Year: 2023
Reference: Clin Microbiol Infect. 2023 Mar;29(3):277-280. doi: 10.1016/j.cmi.2022.11.022. Epub 2022 Dec 1.
Impact factor:
Publication type: Letter or abstract
Authors: Berry, Scott M; Derde, Lennie Pg; Pericas, Juan M et al.
DOI: 10.1016/j.cmi.2022.11.022

Platform trials to overcome major shortcomings of traditional clinical trials in non-alcoholic steatohepatitis? Pros and Cons.

PMID: 36216134
Journal: JOURNAL OF HEPATOLOGY
Year: 2023
Reference: J Hepatol. 2023 Feb;78(2):442-447. doi: 10.1016/j.jhep.2022.09.021. Epub 2022 Oct 8.
Impact factor:
Publication type: Review in international publication
Authors: Aaes-Jorgensen, Anders; Anstee, Quentin M; Anstee, Quentin M; Balthaus, Tania; Capuano, George; de Preville, Natalie; Di Prospero, Nicholas A; Di Prospero, Nicholas A; Duca, Anna; Genesca, Joan et al.
DOI: 10.1016/j.jhep.2022.09.021

Point-of-care ultrasound for tuberculosis diagnosis in children: a Medecins Sans Frontieres cross-sectional study in Guinea-Bissau.

PMID: 37208138
Journal: BMJ Open
Year: 2023
Reference: BMJ Open. 2023 May 19;13(5):e066937. doi: 10.1136/bmjopen-2022-066937.
Impact factor:
Publication type: Paper in international publication
Authors: Alonso, Beatriz; Belard, Sabine; Biague, Evelize; Burza, Sakib; Camara, Miguel; Fonseca, Jamila Vieira; Gallo, Jonathan; Goncalves, Ramiro; Heuvelings, Lotje; Llosa, Augusto E et al.
DOI: 10.1136/bmjopen-2022-066937

Polyoxazoline-Based Nanovaccine Synergizes with Tumor-Associated Macrophage Targeting and Anti-PD-1 Immunotherapy against Solid Tumors.

PMID: 37434063
Journal: Advanced Science
Year: 2023
Reference: Adv Sci (Weinh). 2023 Jul 11:e2300299. doi: 10.1002/advs.202300299.
Impact factor:
Publication type: Paper in international publication
Authors: Acurcio, Rita C; Afonso, Marta B; Arango, Diego; Carreira, Barbara; Florindo, Helena F; Gois, Pedro M P; Graca, Luis; Jordan, Rainer; Martinez-Barriocanal, Agueda; Matos, Ana I et al.
DOI: 10.1002/advs.202300299

Pooled Safety Analysis of Single-Agent Lurbinectedin in Patients With Advanced Solid Tumours.

PMID: 37634282
Journal: EUROPEAN JOURNAL OF CANCER
Year: 2023
Reference: Eur J Cancer. 2023 Jul 28;192:113259. doi: 10.1016/j.ejca.2023.113259.
Impact factor:
Publication type: Paper in international publication
Authors: Boni, Valentina; Brana, Irene; Cullell-Young, Martin; Delord, Jean-Pierre; Fernandez, Cristian; Kahatt, Carmen; Leary, Alexandra; Moreno, Victor; Nieto, Antonio; Oaknin, Ana et al.
DOI: 10.1016/j.ejca.2023.113259

Poor sleep is associated with deficits of attention in COPD patients.

PMID: 37866212
Journal: SLEEP MEDICINE
Year: 2023
Reference: Sleep Med. 2023 Oct 15;112:165-172. doi: 10.1016/j.sleep.2023.10.008.
Impact factor:
Publication type: Paper in international publication
Authors: Ferrer, Jaume; Ferrer, Jaume; Miravitlles, Marc; Miravitlles, Marc; Romero, Odile; Romero, Odile; Saez, Maria; Saez, Maria; Sampol, Gabriel; Sampol, Gabriel et al.
DOI: 10.1016/j.sleep.2023.10.008

Publications